Pharmalot: Biotechs Are Getting Less Venture Capital Backing

"Some biotech stocks may have been on hot recently, but that hasn’t translated into more backing from venture capitalists. The number of biotech venture investments fell by nearly 50 percent in the second quarter, and the dollar amount invested fell by more than 40 percent from the first quarter, according to Thomson Financial data cited by Genetic Engineering & Biotechnology News.
In addition to the decrease in absolute dollars being invested in biotechs over the past year, the proportion of life science dollars going to these companies has shifted compared to medical devices and equipment as well as other healthcare ventures. Biotech’s share of investments made in the life science industry fell to below 40 percent from approximately 45 percent in 2007, the mag writes."